Holen Sie sich die Stockscreener-App
5.39
0.74%
-0.04
Schlusskurs vom Vortag:
$5.43
Offen:
$5.31
24-Stunden-Volumen:
19,497
Relative Volume:
0.06
Marktkapitalisierung:
$322.76M
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-54.64M
KGV:
-4.7796
EPS:
-1.1277
Netto-Cashflow:
$-55.08M
1W Leistung:
+8.89%
1M Leistung:
+27.12%
6M Leistung:
+15.42%
1J Leistung:
+98.89%
1-Tages-Spanne:
$5.2609
$5.4408
1-Wochen-Bereich:
$4.71
$5.51
52-Wochen-Spanne:
$2.20
$5.78
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
5.37 | 326.37M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
522.22 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
800.12 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
999.14 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
139.10 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.35 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Orchestra BioMed CEO David Hochman buys $47,900 in common stock By Investing.com - Investing.com India
Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress - TipRanks
Orchestra BioMed presents investor slide deck detailing AVIM and Virtue SAB programs, strategic partners and 2027 catalysts - TradingView
Orchestra BioMed CEO David Hochman buys $47,900 in common stock - Investing.com
Orchestra BioMed (OBIO) CEO buys more of his own stock - Stock Titan
Orchestra BioMed Grants 133,000 Options to New Hires - MyChesCo
Orchestra BioMed (OBIO) president sells 15,000 shares under trading plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Insider plans to sell 15,000 Orchestra BioMed (OBIO) shares - Stock Titan
Orchestra BioMed (OBIO) CFO logs 3,076-share tax withholding - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) exec cites tax share withholding and son's 2,000-share buy - Stock Titan
Orchestra BioMed (OBIO) officer sees shares withheld for RSU taxes - Stock Titan
Avoiding Lag: Real-Time Signals in (OBIO) Movement - Stock Traders Daily
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Orchestra BioMed CEO to meet investors across two days in September - Stock Titan
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan
Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan
Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan
Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan
Orchestra BioMed (OBIO) Holds Gains at $4.45, Consolidating Between Key Technical LevelsComposite Profile - vinanet.vn
Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st
Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Raises Target Price to $10 - Moomoo
Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView
Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Investing News Network
OBIO Looks 87.4% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Orchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Orchestra BioMed Reports Q2 2026 Results and Updates Progress on BACKBEAT and Virtue Pivotal Trials - Moomoo
Orchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock Titan
Orchestra Biomed Holdings Inc (OBIO) Stock News Today - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra BioMed (OBIO) Insider Darren Sherman Sells 15,000 Shar - GuruFocus
Darren Sherman Sells 15,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock - marketbeat.com
Orchestra BioMed (OBIO) insider sale under 10b5-1 plan on August 3, 2026 - Stock Titan
Orchestra BioMed (OBIO) Projected to Announce Quarterly Earnings on Tuesday - marketbeat.com
Orchestra BioMed (NASDAQ: OBIO) insider details Rule 144 sales of 45,000 shares - Stock Titan
Orchestra BioMed (OBIO) Holds Near $4.00 as Shares Test Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Orchestra Biomed Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
OBIO|Orchestra Biomed Holdings Inc|Price:3.825|Chg%:+0.085 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Income Statement - TradingKey
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):